Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 80425-0297

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 80425-0297). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Description)

Chemical structure of venlafaxine hydrochloride, showing its molecular components including dimethylamino and methoxy groups attached to a cyclohexanol and aromatic benzene ring, with the hydrochloride salt indicated.*

FDA Label Image

Label 1 (Venlafaxine HCl Er 150mg 80425 0297 01)

Packaging label for Venlafaxine hydrochloride ER 150 mg extended-release capsules by Advanced Rx Pharmacy of Tennessee. The label includes storage instructions, a comparison to EFFEXOR ER, lot number, expiration date of 7/31/2025, and a barcode. The package size indicated is #30 capsules.*

FDA Label Image

Label 2 (Venlafaxine HCl Er 150mg 80425 0297 02)

Label for Venlafaxine hydrochloride ER 150 mg capsule by Advanced Rx Pharmacy of Tennessee, LLC. The label includes storage instructions to keep between 20°-25°C (68°-77°F), a comparison to Effexor ER, and product lot and expiration details with an expiration date of 7/31/2025. Package contains 60 capsules.*

FDA Label Image

Label 3 (Venlafaxine HCl Er 150mg 80425 0297 03)

Packaging label for Venlafaxine hydrochloride ER 150 mg capsules, extended release. The label includes the proprietary name, dosage strength, and form. It is labeled by Advanced Rx Pharmacy of Tennessee, LLC. The label also features storage instructions (20-25°C), a lot number placeholder, expiration date 7/31/2025, and compares this product to Effexor ER. Aurobindo Pharma is mentioned in the lot and source information.*

FDA Label Image

Fig 1 (Fig 1)

A scatter plot chart showing pharmacokinetic fold changes and 90% confidence intervals for venlafaxine hydrochloride in various special populations, including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphisms, age over 60 years, and gender differences. The x-axis represents change relative to a reference value, and data points correspond to analytes venlafaxine and its metabolite ODV for Cmax and AUC parameters.*

FDA Label Image

Fig 2 (Fig 2)

A forest plot chart showing fold change and 90% confidence intervals of venlafaxine pharmacokinetic parameters (Cmax and AUC) and oral desvenlafaxine (ODV) relative to various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole (CYP2D6 EM's and PM's), indinavir, metoprolol, imipramine, and lithium. The x-axis represents change relative to the reference value.*

FDA Label Image

Fig 3 (Fig 3)

A scatter plot chart showing the pharmacokinetic (PK) fold changes and 90% confidence intervals for various analytes related to different interacting drugs. The x-axis represents the change relative to a reference value, while the y-axis lists interacting drugs such as Ethanol, Diazepam, Alprazolam, and others along with their analytes and PK parameters (Cmax, AUC). The chart visualizes comparisons of Cmax and AUC values for these drug interactions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.